Volitionrx (VNRX) Return on Sales (2012 - 2025)

Volitionrx has reported Return on Sales for 8 years, with the latest figure at 0.69% in Q4 2025.

• For the quarter ending Q4 2025, Return on Sales fell 55.0% year-over-year to 0.69%; the trailing twelve-month figure through Dec 2025 stood at 0.04% (up 4.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Sales for Q4 2025 stood at 0.69%, down from 0.0% in the prior quarter.
• The five-year high for Return on Sales was 0.05% in Q4 2021, with the low at 0.69% in Q4 2025.
• Historically, Return on Sales has averaged 0.17% across 5 years, with a median of 0.0% in 2025.
• Annual changes were most pronounced in 2021 — Return on Sales soared 19078 bps — and 2023, when it tumbled 61 bps.
• Volitionrx's Return on Sales stood at 0.05% in 2021, then slumped by 85 bps to 0.01% in 2022, then plunged by 4654 bps to 0.36% in 2023, then jumped by 60 bps to 0.14% in 2024, then slumped by 388 bps to 0.69% in 2025.
• The last three Return on Sales figures came in at 0.69% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.